JP2024540164A5 - - Google Patents
Info
- Publication number
- JP2024540164A5 JP2024540164A5 JP2024525599A JP2024525599A JP2024540164A5 JP 2024540164 A5 JP2024540164 A5 JP 2024540164A5 JP 2024525599 A JP2024525599 A JP 2024525599A JP 2024525599 A JP2024525599 A JP 2024525599A JP 2024540164 A5 JP2024540164 A5 JP 2024540164A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- halo
- substituents
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163273228P | 2021-10-29 | 2021-10-29 | |
| US63/273,228 | 2021-10-29 | ||
| PCT/US2022/048277 WO2023076626A1 (en) | 2021-10-29 | 2022-10-28 | Rxfp1 agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540164A JP2024540164A (ja) | 2024-10-31 |
| JP2024540164A5 true JP2024540164A5 (enExample) | 2025-10-30 |
Family
ID=84688378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525599A Pending JP2024540164A (ja) | 2021-10-29 | 2022-10-28 | Ｒｘｆｐ１アゴニスト |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20250221966A1 (enExample) |
| EP (1) | EP4422746A1 (enExample) |
| JP (1) | JP2024540164A (enExample) |
| KR (1) | KR20240099354A (enExample) |
| CN (1) | CN118843613A (enExample) |
| AR (1) | AR127507A1 (enExample) |
| AU (1) | AU2022378644A1 (enExample) |
| CA (1) | CA3234990A1 (enExample) |
| CL (1) | CL2024001268A1 (enExample) |
| CO (1) | CO2024005247A2 (enExample) |
| IL (1) | IL312125A (enExample) |
| MX (1) | MX2024005142A (enExample) |
| PE (1) | PE20241188A1 (enExample) |
| TW (1) | TW202333663A (enExample) |
| WO (1) | WO2023076626A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025031481A1 (zh) * | 2023-08-10 | 2025-02-13 | 深圳信立泰药业股份有限公司 | 一种rxfp1受体调节剂及其制备方法和医药用途 |
| WO2025077841A1 (zh) * | 2023-10-13 | 2025-04-17 | 江苏恒瑞医药股份有限公司 | 酰胺取代的环烷基类化合物、其制备方法及其在医药上的应用 |
| US20250197413A1 (en) | 2023-12-15 | 2025-06-19 | Eli Lilly And Company | Rxfp1 receptor agonists |
| WO2026041118A1 (zh) * | 2024-08-22 | 2026-02-26 | 江苏恒瑞医药股份有限公司 | 酰胺取代的环烷基类化合物、其制备方法及其在医药上的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2929283T3 (es) * | 2012-05-04 | 2022-11-28 | Us Health | Moduladores del receptor de relaxina 1 |
| MX2023006178A (es) * | 2020-12-08 | 2023-06-08 | Astrazeneca Ab | Derivados de acido 4-(2-fluoro-4-metoxi-5-3-(((1-metilciclobutil)m etil)carbamoil)biciclo[2.2.1]heptan-2-il)carbamoil)fenoxi)-1-meti lciclohexano-1-carboxilico y compuestos similares como moduladores de rxfp1 para el tratamiento de insuficiencia cardiaca. |
-
2022
- 2022-10-28 CN CN202280073221.4A patent/CN118843613A/zh active Pending
- 2022-10-28 AU AU2022378644A patent/AU2022378644A1/en active Pending
- 2022-10-28 MX MX2024005142A patent/MX2024005142A/es unknown
- 2022-10-28 PE PE2024000923A patent/PE20241188A1/es unknown
- 2022-10-28 JP JP2024525599A patent/JP2024540164A/ja active Pending
- 2022-10-28 CA CA3234990A patent/CA3234990A1/en active Pending
- 2022-10-28 WO PCT/US2022/048277 patent/WO2023076626A1/en not_active Ceased
- 2022-10-28 US US18/700,349 patent/US20250221966A1/en active Pending
- 2022-10-28 EP EP22830974.6A patent/EP4422746A1/en active Pending
- 2022-10-28 IL IL312125A patent/IL312125A/en unknown
- 2022-10-28 TW TW111141101A patent/TW202333663A/zh unknown
- 2022-10-28 AR ARP220102954A patent/AR127507A1/es not_active Application Discontinuation
- 2022-10-28 KR KR1020247017527A patent/KR20240099354A/ko active Pending
-
2024
- 2024-04-24 CL CL2024001268A patent/CL2024001268A1/es unknown
- 2024-04-24 CO CONC2024/0005247A patent/CO2024005247A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540163A5 (enExample) | ||
| US6262293B1 (en) | ω-Cycloalkly-prostaglandin e2 derivatives | |
| US6235780B1 (en) | ω-cycloalkyl-prostaglandin E1 derivatives | |
| JP2963556B2 (ja) | 抗アテロ−ム性動脈硬化症剤としての新規な２，６−ジ−アルキル−４−シリル−フェノ−ル類 | |
| JP2021514001A5 (enExample) | ||
| JP2024543013A5 (enExample) | ||
| JP3179599B2 (ja) | 縮合ベンゼンオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤 | |
| JP2021534108A5 (enExample) | ||
| JPH08269006A (ja) | 一酸化窒素合成酵素阻害作用を有するアニリン誘導体 | |
| CA2474874A1 (en) | Anticholinergic agents, method for producing the same and use thereof as medicaments | |
| JP2025501509A5 (enExample) | ||
| JPH0739369B2 (ja) | フェニルプロピオン酸誘導体、その製造方法およびそれを有効成分として含有する薬剤 | |
| JP2024536862A5 (enExample) | ||
| US5480998A (en) | Oxime derivative | |
| JP2024546946A5 (enExample) | ||
| JP2024540161A5 (enExample) | ||
| WO2001062708A1 (fr) | Derives d'acide benzoique, procede de production desdits derives, et medicament contenant ces derives comme principe actif | |
| JP2024546943A5 (enExample) | ||
| US4806567A (en) | Method for the treatment of ischemia and reperfusion syndromes | |
| JP2004519441A5 (enExample) | ||
| JP2023537410A5 (enExample) | ||
| JP2024546944A5 (enExample) | ||
| JP2025503442A5 (enExample) | ||
| JP2023533037A5 (enExample) | ||
| JP2022525121A5 (enExample) |